Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-23-020728
Filing Date
2023-02-14
Accepted
2023-02-14 08:02:36
Documents
1
Group Members
CITADEL ADVISORS HOLDINGS LPCITADEL GP LLCCITADEL SECURITIES GP LLCCITADEL SECURITIES GROUP LPCITADEL SECURITIES LLCKENNETH GRIFFIN

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm233236-30_sc13ga.htm SC 13G/A 136137
  Complete submission text file 0001104659-23-020728.txt   137943
Mailing Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131
Business Address SOUTHEAST FINANCIAL CENTER 200 S. BISCAYNE BLVD., SUITE 3300 MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Subject) CIK: 0001798749 (see all company filings)

EIN.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92668 | Film No.: 23622638
SIC: 2834 Pharmaceutical Preparations